FI763529A7 - - Google Patents

Download PDF

Info

Publication number
FI763529A7
FI763529A7 FI763529A FI763529A FI763529A7 FI 763529 A7 FI763529 A7 FI 763529A7 FI 763529 A FI763529 A FI 763529A FI 763529 A FI763529 A FI 763529A FI 763529 A7 FI763529 A7 FI 763529A7
Authority
FI
Finland
Application number
FI763529A
Other languages
Finnish (fi)
Inventor
Pierre Baudet
Jean-Paul Ricard
Adrian Schulthess
Original Assignee
Om Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH17376A external-priority patent/CH616911A5/fr
Priority claimed from CH979076A external-priority patent/CH617175A5/fr
Application filed by Om Lab Sa filed Critical Om Lab Sa
Publication of FI763529A7 publication Critical patent/FI763529A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00—Esters of sulfuric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/16—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Pyridine Compounds (AREA)
FI763529A 1976-01-08 1976-12-08 FI763529A7 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH17376A CH616911A5 (da) 1976-01-08 1976-01-08
CH979076A CH617175A5 (en) 1976-07-30 1976-07-30 Processes for the preparation of mixed polyol esters

Publications (1)

Publication Number Publication Date
FI763529A7 true FI763529A7 (da) 1977-07-09

Family

ID=25683750

Family Applications (1)

Application Number Title Priority Date Filing Date
FI763529A FI763529A7 (da) 1976-01-08 1976-12-08

Country Status (18)

Country Link
JP (1) JPS5285139A (da)
BG (1) BG27537A3 (da)
CA (1) CA1075708A (da)
DD (1) DD128400A5 (da)
DE (1) DE2654951A1 (da)
EG (1) EG12290A (da)
ES (1) ES453795A1 (da)
FI (1) FI763529A7 (da)
FR (1) FR2337552A1 (da)
GB (1) GB1572035A (da)
GR (1) GR61818B (da)
IL (1) IL51039A0 (da)
NL (1) NL7613457A (da)
PL (1) PL117246B1 (da)
PT (1) PT65894B (da)
RO (1) RO70355A (da)
SE (1) SE7613426L (da)
YU (1) YU286476A (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL176551C (nl) * 1979-04-25 1985-05-01 Shell Int Research Werkwijze voor de bereiding van een aromatisch koolwaterstofmengsel door katalytische omzetting van een mengsel van koolmonoxyde en waterstof.

Also Published As

Publication number Publication date
NL7613457A (nl) 1977-07-12
CA1075708A (en) 1980-04-15
DE2654951A1 (de) 1977-07-21
ES453795A1 (es) 1978-01-16
FR2337552A1 (fr) 1977-08-05
GR61818B (en) 1979-01-22
PL194851A1 (pl) 1979-05-07
JPS5285139A (en) 1977-07-15
BG27537A3 (bg) 1979-11-12
PT65894B (fr) 1978-05-18
PL117246B1 (en) 1981-07-31
EG12290A (en) 1979-06-30
SE7613426L (sv) 1977-07-09
RO70355A (ro) 1981-08-17
PT65894A (fr) 1976-12-01
YU286476A (en) 1982-08-31
IL51039A0 (en) 1977-02-28
GB1572035A (en) 1980-07-23
DD128400A5 (de) 1977-11-16

Similar Documents

Publication Publication Date Title
FI770229A7 (da)
FI772345A7 (da)
FI770937A7 (da)
FI770573A7 (da)
FI770167A7 (da)
FR2345737B1 (da)
DE2660696A1 (da)
JPS5390168U (da)
FI770488A7 (da)
FI771449A7 (da)
FR2322631B1 (da)
JPS5729746B2 (da)
JPS5420413B2 (da)
FI772325A7 (da)
FI771118A7 (da)
JPS5755674Y2 (da)
JPS5546733B2 (da)
JPS52124058U (da)
FI772370A7 (da)
JPS5341335U (da)
JPS5323402U (da)
DK142362C (da)
JPS5540681B2 (da)
FI761985A7 (da)
FI761128A7 (da)

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: LABORATOIRES OM S.A.